Consuming too much salt has long been recognized as a primary threat to cardiovascular wellness, strongly linked to hypertension and related health complications. However, a growing body of scientific research indicates that the physiological toll of excessive sodium extends far beyond blood pressure, potentially interfering with cognitive functions, memory retention, and emotional well-being. As high-salt diets remain a pervasive global public health concern, identifying mechanisms to mitigate these neurological and vascular impacts has become an urgent priority for medical researchers worldwide.
In a promising new development, researchers in Japan have identified a potential countermeasure in LPC70, a specialized compound derived from soybeans. While earlier investigations demonstrated that this unique ingredient could alleviate high blood pressure and cognitive impairments associated with high-salt consumption in laboratory mice, the exact biological pathways remained elusive. A comprehensive new study led by Japanese scientists has taken a much deeper look into these mechanisms, revealing that the compound actively influences vital chemical signaling networks located within both the brain and the kidneys.
The findings offer a clearer picture of how dietary interventions might eventually be deployed to protect long-term health against the hidden hazards of excessive sodium intake.
How a Soy Compound May Counter the Effects of Excess Salt
The core of the recent investigation centers on prostaglandins, a group of local signaling molecules synthesized from arachidonic acid, a vital fatty acid. These substances function much like localized hormones, orchestrating and regulating a vast array of essential physiological processes throughout the human body.
Within the cardiovascular network, prostaglandins play a direct role in modulating blood pressure by balancing the complex mechanisms that cause blood vessels to widen and narrow. Their actions within the central nervous system, however, are significantly more intricate and multifaceted. Depending entirely upon which specific cellular receptors they activate, these signaling molecules can trigger cascades that either protect delicate nerve cells from harm or contribute to damaging inflammatory processes. These shifts have the potential to influence higher-order brain functions, including memory retention, cognitive processing, and emotional responses.
LPC70 itself is a specialized form of soy lysolecithin in which lysophosphatidylcholine, commonly referred to as LPC, accounts for more than 70 percent of the total phospholipid content. Although preceding laboratory experiments established that LPC70 could ease salt-induced hypertension and cognitive deficits, scientists previously lacked a comprehensive understanding of the precise molecular pathways responsible, particularly its precise influence on prostaglandin signaling dynamics.
To bridge this knowledge gap, a dedicated research team embarked on a detailed investigation. The group was led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani, examining how the introduction of LPC70 altered these specific signaling pathways in mice maintained on a high-salt diet.
Dr. Kubota, serving as the study’s first author, coordinated the day-to-day execution of the laboratory experiments. His responsibilities included measuring fluctuations in blood pressure, recording subtle behavioral modifications, and analyzing the underlying molecular activity tied to prostaglandin pathways. His meticulous work ultimately helped clarify how LPC70 exerts differential, organ-specific effects in the precise tissues most vulnerable to salt-related cardiovascular and cognitive dysfunction.
Prof. Mouri and Dr. Kubota hold academic appointments within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside affiliations with the International Center for Brain Science at Fujita Health University. Meanwhile, Dr. Kagotani contributes his expertise through affiliations with Tsuji Oil Mills Co., Ltd., in Japan, and the Tsuji Health and Beauty Science Laboratory at Mie University.
The peer-reviewed findings were initially released online on May 14, 2026, and subsequently published in Volume 197 of the academic journal Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Prof. Mouri, discussing the impetus behind the investigation. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," he added.
Soy Compound Improves Blood Pressure and Memory in Mice
As anticipated by the research team, laboratory mice placed on a high-salt diet quickly developed significantly elevated blood pressure levels. However, the physiological consequences of the high-sodium regimen extended well beyond simple cardiovascular strain.
Behavioral analyses revealed that the animals also experienced a noticeable decline in social interaction and struggled significantly with recognizing objects they had encountered previously, clear indicators of disrupted memory performance. Interestingly, the mice displayed no substantial alterations in general locomotor activity or generalized anxiety-like behaviors. This selective behavioral disruption suggests that excessive sodium intake targets specific, complex cognitive and social neural circuits rather than inducing widespread, non-specific impairment across all behavioral domains.
When the researchers supplemented the high-salt diets of these animals with LPC70, a distinct reversal of several adverse effects was observed. Not only did the mice experience an improvement in blood pressure regulation, but they also performed markedly better during standardized evaluations of social interaction and object recognition memory.
These encouraging macroscopic improvements provided the vital impetus for the research team to investigate the microscopic changes occurring within the internal organs of the subjects.
Different Protective Effects in the Kidneys and Brain
To uncover the cellular underpinnings of these benefits, the scientists analyzed tissue samples from both the renal systems and the central nervous systems of the test subjects.
Within the kidneys, maintaining a high-salt diet led to a marked upregulation of two key molecular components involved in prostaglandin synthesis and signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these biological factors are strongly suspected of driving the development of salt-sensitive hypertension.
The administration of LPC70 successfully suppressed these salt-induced elevations. This indicated that the soy-derived compound helps correct aberrant signaling profiles in the kidneys that would otherwise disrupt normal, healthy blood pressure control.
Conversely, the researchers discovered a completely different pattern of response within the prefrontal cortex, a critical region of the brain responsible for executive function, higher-level thinking, memory formation, and social behavior.
Excess salt consumption led to a reduction in the expression of the PGD2 receptor DP1, a protein that normally facilitates protective and anti-inflammatory signaling pathways inside the neural tissue. Remarkably, treatment with LPC70 restored the expression levels of this specific protective receptor without altering DP2, a secondary receptor linked to potentially neurotoxic or harmful effects on nerve cells.
This nuanced distinction is considered highly significant by the researchers, as it demonstrates that LPC70 does not act as a blunt instrument that merely amplifies or suppresses all prostaglandin activity indiscriminately. Instead, the compound appears to selectively favor and restore signaling pathways that safeguard the brain against damage, offering a plausible molecular explanation for the observed recoveries in memory and social interaction among the test subjects.
A Surprising Change in Chemical Signaling
In addition to mapping receptor expression, the investigation uncovered an unexpected biochemical shift involving arachidonic acid, the essential fatty acid utilized by mammalian bodies as the foundational building block for prostaglandin production.
Mice subjected to a high-salt diet exhibited lower levels of circulating arachidonic acid in their systems. Yet, paradoxically, when these same animals were treated with LPC70, the tissue levels of downstream prostaglandins derived from this fatty acid—specifically including PGE2 and PGD2—actually increased.
This seemingly contradictory biochemical result points to a more sophisticated mechanism of action. The data suggest that LPC70 may optimize the body’s metabolic efficiency, enabling it to utilize available pools of arachidonic acid more effectively to generate protective prostaglandins even under the adverse biochemical stress of a high-sodium environment.
When viewed comprehensively, the experimental data highlight a coordinated yet remarkably selective biological response. Within the renal system, LPC70 appears to downregulate signaling cascades associated with hypertension, while inside the brain, it restores neuroprotective and anti-inflammatory signaling networks. The overall therapeutic impact of the compound is thus dependent upon both the specific target organ involved and the precise profile of prostaglandin receptors being modulated.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings suggest that LPC70 holds genuine potential to be developed into a functional food ingredient or dietary supplement aimed at mitigating some of the most detrimental health consequences linked to chronic high-salt consumption.
Its demonstrated capacity to concurrently improve both cardiovascular metrics and cognitive performance in an animal model raises the exciting possibility that similar nutritional interventions could eventually support human brain and heart health, particularly among populations whose traditional or modern diets feature high concentrations of sodium.
Nevertheless, researchers emphasize that the current data are derived exclusively from preclinical animal studies. Extensive clinical trials involving human participants will be strictly required before any definitive claims can be made regarding whether these same protective benefits translate to people.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri, summarizing the broader vision of the research initiative.
The published study provides a far more detailed, molecular-level understanding of how a naturally derived food component can influence the body’s complex physiological responses to excessive salt intake, opening new avenues for nutritional science in the quest to safeguard long-term human health.
The research was made possible through financial backing from multiple institutional and private sources, including Grants-in-Aid for Scientific Research provided by the Japan Society for the Promotion of Science under award numbers 20K07931, 22K07606, 22K11891, and 23H02843. Additional backing was delivered by the Fujita Mind-Brain Research & Innovation Center for Drug Generation through Japan’s Peak Research Universities Program, alongside the Japan Science and Technology Agency FOREST Program. Financial contributions were also provided by Tsuji Oil Mills Co., Ltd., the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.